Oxford Asset Management’s Eli Lilly LLY Stock Holding History

Oxford Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343K	Buy	+286	New	+$292K	0.17%	171
2024 Q3	–	Sell	-378	Closed	-$342K	–	387
2024 Q2	$342K	Buy	+378	New	+$302K	0.33%	111
2019 Q4	–	Sell	-67,448	Closed	-$7.54M	–	1935
2019 Q3	$7.54M	Sell	67,448 -23,528	-26%	-$2.62M	0.18%	147
2019 Q2	$10.1M	Buy	90,976 +77,714	+586%	+$9.15M	0.22%	90
2019 Q1	$1.72M	Sell	13,262 -43,874	-77%	-$5.34M	0.04%	660
2018 Q4	$6.61M	Sell	57,136 -51,486	-47%	-$5.75M	0.17%	142
2018 Q3	$11.7M	Buy	108,622 +17,625	+19%	+$1.76M	0.24%	71
2018 Q2	$7.8M	Buy	90,997 +39,196	+76%	+$3.22M	0.15%	144
2018 Q1	$4.01M	Sell	51,801 -34,935	-40%	-$2.81M	0.08%	248
2017 Q4	$7.35M	Sell	86,736 -12,793	-13%	-$1.09M	0.16%	135
2017 Q3	$8.43M	Sell	99,529 -14,786	-13%	-$1.21M	0.16%	104
2017 Q2	$9.41M	Buy	114,315 +86,516	+311%	+$7.06M	0.19%	87
2017 Q1	$2.34M	Buy	+27,799	New	+$2.23M	0.06%	402

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Oxford Asset Management's LLY Position: Q2 2026 in Review

Oxford Asset Management opened a new position in Eli Lilly (LLY) in Q2 2026: 286 shares worth $343K. The stake represents 0.17% of the portfolio and ranks #171 among its holdings. This is a return to the name: Oxford Asset Management previously reported a position in LLY as recently as Q2 2024.

Oxford Asset Management first reported a position in LLY in Q1 2017 and has held it in 13 quarters since. The position peaked at $11.7M in Q3 2018. 4,641 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Oxford Asset Management held 286 shares of Eli Lilly worth $343K as of Q2 2026.
Eli Lilly was a new Oxford Asset Management position in Q2 2026.
Eli Lilly made up 0.17% of Oxford Asset Management's portfolio in Q2 2026, its #171 holding.
Oxford Asset Management first reported a position in Eli Lilly in Q1 2017 and has held it in 13 quarters since.
Oxford Asset Management's Eli Lilly position peaked at $11.7M in Q3 2018.
4,641 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.